Glow LifeTech (TSE:GLOW)
:GLOW
Want to see TSE:GLOW full AI Analyst Report?
GLOW Stock Chart & Stats
C$0.06
>-C$0.01(-7.69%)
At close: 4:00 PM EST
C$0.06
>-C$0.01(-7.69%)
Day’s Range― - ―
52-Week RangeC$0.05 - C$0.08
Previous CloseN/A
Volume6.00K
Average Volume (3M)266.05K
Market Cap
C$10.57M
Enterprise ValueC$9.26M
Total Cash (Recent Filing)C$1.37M
Total Debt (Recent Filing)C$56.19K
Price to Earnings (P/E)374.0
Beta0.33
Next Earnings
May 28, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)<0.01
Shares Outstanding192,235,550
10 Day Avg. Volume165,602
30 Day Avg. Volume266,047
Financial Highlights & Ratios
PEG Ratio0.19
Price to Book (P/B)3.82
Price to Sales (P/S)5.04
P/FCF Ratio-87.53
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Revenue GrowthSustained revenue ramp from C$0.84M to C$2.05M indicates improving commercial traction and growing demand. Over months this supports fixed-cost absorption, potential margin expansion, and strengthens the company’s ability to scale operations and attract partners or follow-on funding.
Improved Operating Cash FlowOperating cash flow improving to near breakeven reflects tighter spending or better working-capital dynamics. This materially extends runway, reduces immediate financing pressure, and gives management flexibility to prioritize investment in growth or pathway milestones without urgent dilution.
Lower Leverage / Balance Sheet CushionSignificantly reduced debt and positive equity provide a balance-sheet cushion, lowering refinancing and interest risks. Manageable leverage enhances strategic optionality, supports continued R&D or commercial investment, and improves resilience through typical early-stage biotech volatility.
Bears Say
Negative Free Cash FlowDespite improvement, free cash flow remained negative (~-C$0.12M) in 2025, meaning operations do not yet self-fund. Persistent negative FCF requires external capital or dilution to sustain growth and R&D, constraining long-term strategic choices until positive cash generation is achieved.
Weak Profitability / Negative ReturnsNegative ROE and operating losses indicate the company is not generating sufficient returns on capital. This limits internal capital formation, hinders reinvestment capacity, and raises the bar for achieving durable margins as revenue scales, prolonging reliance on external funding.
Small Scale And VolatilityGrowth is from a very small base and equity has been volatile, reflecting early-stage execution risk. Small scale makes margins and cash generation lumpy, increases sensitivity to single-product or customer outcomes, and elevates the impact of any operational setbacks on long-term financial durability.
Glow LifeTech News
GLOW FAQ
What was Glow LifeTech’s price range in the past 12 months?
Glow LifeTech lowest stock price was C$0.04 and its highest was C$0.07 in the past 12 months.
What is Glow LifeTech’s market cap?
Glow LifeTech’s market cap is C$10.57M.
When is Glow LifeTech’s upcoming earnings report date?
Glow LifeTech’s upcoming earnings report date is May 28, 2026 which is in 9 days.
How were Glow LifeTech’s earnings last quarter?
Glow LifeTech released its earnings results on May 05, 2026. The company reported C$0 earnings per share for the quarter, the consensus estimate of N/A by C$0.
Is Glow LifeTech overvalued?
According to Wall Street analysts Glow LifeTech’s price is currently Overvalued.
Does Glow LifeTech pay dividends?
Glow LifeTech does not currently pay dividends.
What is Glow LifeTech’s EPS estimate?
Glow LifeTech’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Glow LifeTech have?
Glow LifeTech has 192,235,550 shares outstanding.
What happened to Glow LifeTech’s price movement after its last earnings report?
Glow LifeTech reported an EPS of C$0 in its last earnings report, expectations of N/A. Following the earnings report the stock price went up 11.111%.
Which hedge fund is a major shareholder of Glow LifeTech?
Currently, no hedge funds are holding shares in TSE:GLOW
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Glow LifeTech
Glow Lifetech Corp., a biotechnology company, focuses on producing nutraceutical and cannabinoid-based products in North America. The company engages in the commercialization of two technologies, such as MyCell Enhanced technology, a nutraceutical and cannabis nutrient delivery technology; and a cannabis Smart Consumption System to assist users and patients to store, journal, control, consume, and manage cannabis related products. The company has the exclusive North American rights for the production, sale, and distribution rights for the certain micellization technology for cannabis and hemp derived ingredients, curcumin, vitamin K, and iron. It also engages in the business of secondary processing of ingredients to produce micellized materials from certain vitamins, nutraceuticals, and cannabis extracts that makes fat-soluble substances available for immediate absorption into the body reach near 100% bioavailability and water compatibility. The company was incorporated in 2018 and is based in Toronto, Canada.
Technical Analysis
COSCIENS Biopharma
―
Kane Biotech
―
Quest Pharmatech
―
PreveCeutical Medical
―
PharmAla Biotech Holdings, Inc.
―
Options Prices
Currently, No data available
---